{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T03:40:32Z","timestamp":1769658032922,"version":"3.49.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,28]]},"DOI":"10.7759\/cureus.102477","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:37:33Z","timestamp":1769614653000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Pyelonephritis in Quadriplegia: Rethinking Oral Cefdinir in the Presence of Nephrolithiasis"],"prefix":"10.7759","author":[{"given":"Mahsum","family":"Jafri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhayr","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantino G","family":"Lambroussis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/828275","article-title":"Interactions of constipation, dysfunctional elimination syndrome, and vesicoureteral reflux","volume":"2008","author":"Halachmi S","year":"2008","unstructured":"Halachmi S, Farhat WA. Interactions of constipation, dysfunctional elimination syndrome, and vesicoureteral reflux. Adv Urol. 2008, 2008:828275. 10.1155\/2008\/828275","journal-title":"Adv Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S549804","article-title":"Dysbiotic gut microbiota correlates with altered serum and urinary biomarkers in recurrent calcium oxalate stone patients","volume":"18","author":"Zhang B","year":"2025","unstructured":"Zhang B, Li T, Qiang Z, Ma L, Kong X, Chen S. Dysbiotic gut microbiota correlates with altered serum and urinary biomarkers in recurrent calcium oxalate stone patients. Int J Gen Med. 2025, 18:6497-506. 10.2147\/IJGM.S549804","journal-title":"Int J Gen Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.22207\/jpam.18.4.44","article-title":"Exploring the connection between bacterial biofilms and renal calculi: a comprehensive review","volume":"26","author":"Mohankumar A","year":"2024","unstructured":"Mohankumar A, Ganesh R, Shanmugam P. Exploring the connection between bacterial biofilms and renal calculi: a comprehensive review. J Pure Appl Microbiol. 2024, 26:2262-83. 10.22207\/jpam.18.4.44","journal-title":"J Pure Appl Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf501","article-title":"Cefdinir versus cephalexin for the treatment of uncomplicated urinary tract infections","volume":"12","author":"Mitzner TM","year":"2025","unstructured":"Mitzner TM, Eid KM, Hughson DM, Jameson AP, Dumkow LE. Cefdinir versus cephalexin for the treatment of uncomplicated urinary tract infections. Open Forum Infect Dis. 2025, 12:ofaf501. 10.1093\/ofid\/ofaf501","journal-title":"Open Forum Infect Dis"},{"key":"ref5","article-title":"Levofloxacin","author":"Podder V","year":"2025","unstructured":"Podder V. Levofloxacin. StatPearls (Internet). StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref6","article-title":"Urinary tract infection in the neurogenic bladder","volume":"5","author":"Vigil HR","year":"2016","unstructured":"Vigil HR, Hickling DR. Urinary tract infection in the neurogenic bladder. Transl Androl Urol. 2016, 5:72.","journal-title":"Transl Androl Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2024.10.003","article-title":"Incidence of and risk factors for urinary stones among patients with spinal cord injury: a systematic review with meta-analysis","volume":"70","author":"Zhang W","year":"2024","unstructured":"Zhang W, Shen R, Shang Z, et al.. Incidence of and risk factors for urinary stones among patients with spinal cord injury: a systematic review with meta-analysis. Eur Urol Open Sci. 2024, 70:79-85. 10.1016\/j.euros.2024.10.003","journal-title":"Eur Urol Open Sci"},{"key":"ref8","unstructured":"National Institutes of Health. Cefdinir for oral suspension USP (Internet). (2025). Accessed: December 10, 2025: https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=37b5d000-db9e-4b6e-8208-6361e98fb55d&type=display."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121673","article-title":"Fluoroquinolones and biofilm: a narrative review","volume":"17","author":"Geremia N","year":"2024","unstructured":"Geremia N, Giovagnorio F, Colpani A, et al.. Fluoroquinolones and biofilm: a narrative review. Pharmaceuticals (Basel). 2024, 17:1673. 10.3390\/ph17121673","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450210-recurrent-pyelonephritis-in-quadriplegia-rethinking-oral-cefdinir-in-the-presence-of-nephrolithiasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:37:34Z","timestamp":1769614654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450210-recurrent-pyelonephritis-in-quadriplegia-rethinking-oral-cefdinir-in-the-presence-of-nephrolithiasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.102477","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}